Human beta-NGF Recombinant Protein, PeproTech
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0446921
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $440.02
About this award
The University of Virginia awarded contract A207_PO-0446921 to Life Technologies Corporation on June 9, 2026, for the procurement of specialized biotechnology materials. The contract encompasses the delivery of Human Beta-Nerve Growth Factor (NGF) Recombinant Protein, manufactured by PeproTech, to be delivered to Matthew S Loftus. The cumulative contract value is $440.02, reflecting a single unit purchase at a unit price of $440.02.
This acquisition represents a straightforward purchase order for research-grade biological reagents to support the University of Virginia's research operations in Virginia. Life Technologies Corporation served as the prime contractor responsible for procuring and delivering the specified recombinant protein product. The contract documentation does not specify an extended performance period, suggesting this constitutes a one-time purchase order rather than an ongoing service agreement.
Line items
| Item | Total |
|---|---|
| Human beta-NGF Recombinant Protein, PeproTech | $440.02 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0446921?
Contract A207_PO-0446921 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on June 9, 2026.
How much is contract A207_PO-0446921 worth?
Its cumulative value is $440.02.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award